Prevalence rates are also high among certain ethnicities; 10%–12% of breast cancers in the Ashkenazi Jewish population, unselected for family history, are attributable to mutations in BRCA1 or BRCA2 [13]. This evidence concerns the gene BRCA1 and breast carcinoma.